Latest Industry News & Trends
Market Scope provides comprehensive coverage of the ophthalmic market. Our news stories are a combination of public and proprietary content ranging from coverage of international meetings, surgeon survey results and trends, analysis of company financial reports and public medical registries, press releases, and interviews with executives. Register today to receive free weekly email updates, our top data chart, surgeon poll results, and much more. Locked content can be accessed through a subscription to our ophthalmic industry newsletters.
Recently Added News
Aier Eye Hospital Group to Buy 25 VisuMax 800 Lasers from Zeiss
German company Carl Zeiss Meditec reported June 17 that the Aier Eye Hospital Group in China had agreed to buy 25 VisuMax 800 femtosecond lasers for its hospital locations starting this year. The V...
Johnson & Johnson to Invest $1 Billion in Jacksonville, Home of J&J Vision
Johnson & Johnson reported June 15 that it would invest more than $1 billion in its Jacksonville, Florida, operations to scale US-based manufacturing, packaging, and distribution capabilities for i...
Belite Bio Completes Rolling NDA Submission for Oral Tinlarebant in Stargardt
Belite Bio announced June 12 that it had completed its rolling new drug application (NDA) submission to the US FDA for oral tinlarebant for the treatment of Stargardt disease. The San Diego, Califo...
2026 ARVO Meeting Draws Big Attendance, Rare Snowstorm
The 2026 meeting of the Association for Research in Vision and Ophthalmology (ARVO) drew 10,996 attendees, the second largest attendance to date, coming in just under the 2024 total of 11,631. The ...
J&J Expands US Rollout of Tecnis PureSee IOL
Johnson & Johnson reported June 11 that it was expanding availability for the Tecnis PureSee IOL in the US. The lens gained US FDA approval in March 2026. The PureSee is a purely refractive extende...
Alcon Launches Unity CS Phaco System in Canada
Alcon announced June 15 the launch in Canada of the Unity CS phacoemulsification system for cataract surgery. Alcon said it planned to showcase the platform at the Canadian Ophthalmological Society...
Tavo Biotherapeutics Appoints Federico Grossi, MD, PhD, as CMO
Tavo Biotherapeutics, of Laguna Beach, California, announced June 2 that it had appointed Federico Grossi, MD, PhD, as chief medical officer (CMO). Grossi most recently was CMO of Unity Biotechnolo...
TearSolutions Gains Orphan, Fast Track Status for Lacripep in Neurotrophic Keratitis
TearSolutions announced June 2 that the US FDA had granted orphan drug and fast track designations for its synthetic peptide eye drop candidate Lacripep in neurotrophic keratitis (NK). NK is a rare...
Regulatory Changes, Off-Brand Competition Reshape Ophthalmic Market in China
Continued change is shifting the dynamics of the ophthalmic market in China, boosting revenue growth in some sectors while slowing it in others. Changes are both regulatory and competitive. Regulat...
EBAA Annual Meeting Underlines Human Impact of Donation
The 2026 Eye Bank Association of America (EBAA) annual meeting brought together approximately 250 eye bank technicians, medical directors, corneal surgeons, and industry professionals June 3-6 in I...
Ophthalmic Company Revenue Increases 3.7 Percent in First Quarter of 2026
Ophthalmic manufacturer revenue in Q1-2026 totaled $11.4 billion. Revenue increased 3.7 percent from the same quarter in 2025 and decreased 2.9 percent from Q4-2025. The total includes Market Scope...
Ophthalmologists Report 4.7 Percent Decrease in Q1-2026 Procedure Volume
US ophthalmologists reported that ophthalmic procedures decreased 4.7 percent in Q1-2026 compared with the same quarter in 2025, according to Market Scope’s latest survey. Year-over-year performanc...
Past News Stories
SpyGlass Gains Category III CPT Code for Its Drug-Eluting BIM-IOL System
SpyGlass Pharma, of Aliso Viejo, California, reported May 18 that the American Medical Association had approved a new add-on Category III CPT code that will allow surgeons to be reimbursed separate...
Oculis Scraps DME Eye Drop Program after Missing Phase III Endpoints
Swiss company Oculis reported May 29 that it would not pursue US FDA approval for OCS-01, its dexametha-sone eye drop candidate targeting diabetic macular edema (DME), after the primary endpoint of...
Select US FDA Approvals and Clearances in May 2026
The US FDA’s ophthalmic device division granted clearance to two devices using the 510(k) pathway in May 2026, according to the agency’s database. Heidelberg received clearance for its updated Spec...
PDUFA Dates for Ophthalmic Drug Candidates
The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.
US FDA Commissioner Makary Resigns After Rocky Year in Top Job
US FDA Commissioner Marty Makary, MD, MPH, resigned May 12 after a rocky year in the agency’s top job that saw mass layoffs, high-level resignations, and policy fights with lawmakers, drugmakers, a...
ViaLase Announces First Commercial FLIGHT Procedures in Glaucoma Patients
ViaLase, of Aliso Viejo, California, announced May 26 that surgeons in London and Germany had performed the first commercial procedures using its ViaLuxe Laser System for femtosecond laser image-gu...
Ethyreal Bio Leads Latest Fundraising with $101 Million in Series A
Ethyreal Bio led recent ophthalmic fundraising efforts with $101 million in a Series A financing to advance its subcutaneous candidate for thyroid eye disease. Financing announced in the past four ...
Eyecelerator@ARVO and All Access Saturday Look at Business Side of Developing Therapeutics
May 1 marked the start of a new era for Eyecelerator, the organizer of ophthalmology innovation business conferences. It was the first time Eyecelerator was officially part of ARVO (Association for...
2026-2027 Ophthalmic Meetings Calendar
Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.
2026 ARVO Keynote Speaker Says ‘Age of RNA’ Has Arrived
Thomas Cech, PhD, declared the 21st century “the age of RNA” during his opening keynote address at the 2026 ARVO meeting. Sally Temple, PhD, used the closing keynote to talk about the future of ste...
AI Sessions at 2026 ARVO Meeting Move Past the Hype
The conversation around AI in ophthalmology has evolved over the past three years. The emphasis at the 2026 ARVO meeting and the Focus A-Eye Summit was on how to bridge the gap between innovation a...
New Blood Collection Strategies Aim to Expand Supply of Donor Tissue for Cornea Transplants
Researchers at the 2026 EBAA meeting shared a new approach to increasing the supply of donor corneal tissue: improving blood collection practices. Efforts to expand tissue availability have usually...
Want to Read the Full Article?
Already Have an Account?
Register A Corporate Account
A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.